Why Veterans With PTSD Are Turning to Psychedelics: ibogaine treatment stories, VETS nonprofit, and related clinical research

Ibogaine is presented as a medically supervised option that some veterans with PTSD and treatment-resistant symptoms pursue, often outside the US where it is in a legal gray area. The story centers on Navy SEAL veteran Marcus Capone and the nonprofit VETS (Veterans Exploring Treatment Solutions), which sponsors thousands of psychedelic-assisted treatments and screens applicants for risks like heart conditions and family history of psychosis. The article describes the treatment journey including concerns about safety and unpleasant side effects reported by participants, plus clinic safeguards such as cardiac monitoring and magnesium support. It also links these personal accounts to claims from a Stanford study of special forces veterans with traumatic brain injury, reporting large average symptom reductions for PTSD, depression, and anxiety after ibogaine, alongside improvements on cognitive testing. The article further discusses other psychedelic options mentioned for veterans and suicidality, notes calls for more research and for medical access rather than legalization, and references publicly funded psychedelic research efforts in Texas.